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Abstract
Introduction: Brain glioma is the most common and 
lethal primary malignant intracranial tumor. Nonethe-
less, gross tumor resection remains the most success-
ful treatment modality, which may prolong progres-
sion free survival of these patients. However, excessive 
surgery brings a danger of neurological, regional and 
systemic complications, which may be diminished/
avoided by better pre- and intra-operative care and by 
modern neurosurgical techniques.
Aim: To analyze the incidence and type of peri- and 
post-operative complications in surgical brain glioma 
patients. Computing the results, advice on complica-
tion prevention was made.
Methods: A single institution series of brain glioma pa-
tients operated on during a two-year period was ana-
lyzed. The incidence, type and time of complications 
were observed, as well as the patients’ gender and age, 
and the extent of tumor resection complications, di-
chotomized as peri- and post-operative variables, were 
correlated with investigated parameters to find out 
their possible association.
Results: Transitory neurological deficit was the most 
common peri-operative complication. Seizures, men-
ingitis, and permanent neurological deficit were com-
monly recorded among post-operative complications. 
Conclusion: Patients’ gender and age, and the extent 
of tumor resection were not influential to the develop-
ment of brain glioma complications. Aggressive surgery 
requires the avoidance of complications by cautious 
patient selection, multidisciplinary preoperative plan-
ning, and scrupulous neurosurgical technique aug-
mented by up-to-date armamentarium. 
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at the Department of Neurosurgery of Sestre milosrdnice 
University Hospital Center, Zagreb, Croatia, searching for 
various types of surgical/medical complications. 
The investigated parameters were patients’ gender and 
age, and the extent of tumor resection. Complications, di-
chotomized as peri- and post-operative variables were an-
alyzed to find out possible correlation between the inves-
tigated parameters and incidence/type of complications.
The peri-operative complications were defined as tran-
sient neurological deficit/temporary motor weakness, 
speech difficulties, and intracranial hematoma. The 
post-operative complications included seizures, infec-
tive complications (meningitis/pneumonia), and per-
manent neurological deficit/motor weakness, as well 
as cerebrospinal fluid (CSF) leak due to local wound 
dehiscence, and deep venous thrombosis.
Local ethics committee approval and informed consent 
from each patient were obtained before the beginning 
of the study. 
Statistical analysis
The difference between investigated variables was sta-
tistically analyzed using the Chi-square test. The sig-
nificance was set at Alpha = 0.05. The program SPSS for 
Windows, version 16.0 (SPSS Inc., Chicago, Illinois, USA) 
was used for statistical analysis of the published data.
Results 
The total number of surgical glioma patients was 66 
with male to female ratio of 32:34. The mean age of 
the group was 49.2 years. The most affected age group 
was that of 60-69 years, which included 22 (33.3%) pa-
tients, followed by 70-79 age group, which numbered 
17 (25.7%) patients (P < 0.001) (Table 1). 
Gross tumor resection was performed in 30 (45.5%), 
partial (subtotal) tumor resection in nine (13.5%), and 
stereotactic biopsy in 27 (41.0%) patients (P  =  0.003) 
(Table 2), 21 (77.7%) of whom were older than 60 years.
Introduction
Brain glioma is the most common and lethal primary 
malignant intracranial tumor with annual incidence of 
up to 9/100.0001, 2. In spite of the advances in diagnostics 
and therapy, overall survival continues to be poor. Gross 
tumor resection remains the most successful treatment 
modality regardless of the glioma malignancy grade 
and/or improvements in adjuvant therapies3, 4. Progres-
sion free survival in these patients is mainly related to 
the extent of tumor resection5, which may assure long-
term glioma remission and provide disease control when 
combined with adjuvant therapy. However, surgery 
brings the danger of neurological, regional and systemic 
complications6, such as iatrogenic peri-operative cor-
tical/vascular injury, surgical wound dehiscence, and 
various post-surgical medical obstacles. The risk for and 
development of such complications may be heavily influ-
enced by certain parameters like tumor histopathology, 
age, and functional impairment score3, 7. 
Complications are defined as any aberration from the or-
dinary post-operative course happening within 30 days 
post-surgery8. It is known that the brain glioma surgery 
carries an increased risk of complications, including iat-
rogenic stroke, intracranial hemorrhage, and meningitis 
as the most common ones6. Since such complications are 
more related to the procedure itself, they are considered 
life-threatening surgical complications8.  Nonetheless, 
the complication rates became considerably diminished 
due to the advancements in pre- and intra-operative care 
and modern surgical techniques. 
The aim of this article was to analyze the incidence and 
type of various peri- and post-operative complications 
appearing in surgical glioma patients. Computing the 
results of a single institution series, the advice on com-
plication prevention methods was made.
Material and Methods 
In a retrospective study, we analyzed a single institution 
series of brain glioma patients who were operated on 
during a two-year period (January 2019 - December 2020) 
Rotim K. et al. Strategies for the Prevention of Complications in Brain Glioma Surgery: a Case Series Analysis. J. appl. health sci. 2021; 7(2): 115-120 117
(9.5%) patients developed CSF leak due to local wound 
dehiscence. Deep venous thrombosis and pneumonia 
were recorded in one (4.8%) patient each (Table 3). 
The extent of tumor resection, as well as patients’ gen-
der and age were not correlated to the frequency and 
type of peri- and post-operative complications. The dif-
ference between the investigated variables was not sta-
tistically significant.
Most complications gradually subsided after sympto-
matic and/or antimicrobial treatment and during the 
in-hospital patients’ stay, except seizures and perma-
nent neurological deficit.
Discussion
Surgery is the preferred and primary method of choice 
in the treatment of brain glioma. However, it carries the 
risk for the development of various complications en-
dangering the management outcome and functional 
recovery, as well as the quality of life of such patients. 
The most affected age group in our series was that of 
60-69 years old, followed by 70-79 years old (Table 1), 
what is consistent with the literature data indicating 
that the incidence of malignant brain glioma increases 
with age, being primarily identified in elderly patients 
with a median age of 64 at diagnosis9. 
The infiltrative and aggressive nature of tumor growth 
is very well-established characteristic of brain glioma 
Table 1. Age distribution of glioma surgical 
patients
Age group N % P*
30-39 years 2 3.0
< 0.001
40-49 years 8 12.1
50-59 years 13 19.7
60-69 years 22 33.3
70-79 years 17 25.8
80-89 years 4 6.1
Total 66 100
*Chi-square Test
Table 2. Extent of tumor resection
Type of surgery N % P*
gross total resection 30 45.5
0.003subtotal resection 9 13.5
stereotaxic biopsy 27 41.0
Total 66 100
*Chi-square Test
The incidence of overall complications following brain 
glioma surgery is depicted in Table 3. In the series of 66 
surgical glioma patients, seven (10.6%) patients develo-
ped peri-operative complications, while post-operative 
complications were recorded in 21 (31.8%) of them (Ta-
ble 3). Peri-operative complications included: transient 
neurological deficit together with temporary motor we-
akness, speech difficulties, and intracranial hematoma 
(Table 3). Among post-operative complications, there 
were seven (33.3%) patients with seizures, five (23.8%) 
patients with meningitis, and five (23.8%) with perma-
nent neurological deficit (motor weakness), while two 
Table 3. Type and incidence of complications
Type of complication
Overall Peri-operative Post-operative
N % N % N %
seizures 7 25.0 7 33.3
transitional neurological deficit 6 21.4 6 85.7
permanent neurological deficit 5 17.8 5 23.8
meningitis 5 17.8 5 23.8
CSF leak 2 7.2 2 9.5
intracranial hematoma 1 3.6 1 14.3
pneumonia 1 3.6 1 4.8
deep venous thrombosis 1 3.6 1 4.8
Total 28 100 7 100 21 100
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of the surgical anatomy and mindfulness of possible 
neurosurgical drawbacks are also extremely helpful in 
reducing the rate of complications and maximizing tu-
mor resection25. A substantial amount of complications 
in glioma surgery may be avoided by using standard-
ized operative protocols, and improved teamwork26. We 
have followed the above postulates while performing 
surgery on our patients. 
Considering the results of this paper, patients’ gender 
and age, and the extent of tumor resection were not in-
fluential to the development of glioma complications. 
In general, an acceptable proportion of glioma surgery 
complications was recorded in our series. Non-life-
threatening complications that were treated without 
invasive procedures were mostly observed. Complica-
tions requiring invasive management, as well as life-
threatening complications were encountered rarely. 
No in-hospital deaths as a result of complications were 
documented in our series at all. Nevertheless, one has 
to always be mindful of possible complications and has 
to be particularly cautious while performing glioma 
surgery using the state-of-the-art armamentarium to 
prevent them. 
At the end of this paper, it is compulsory to address cer-
tain study limitations generating from its retrospective 
character and the fact that only in-hospital complicati-
ons could be identified, since most of the patients were 
lost to follow up after discharge due to subsequent on-
cological treatment.
Conclusion
Our results may be helpful to assist treatment strategi-
es in the diminishment of operative risks and preven-
tion of post-operative complications in patients under-
going surgery for brain glioma, regardless of their age. 
Prospective, randomized studies on a broader material 
are needed to corroborate our results.
pathophysiology. Hence, the debate and controversy 
over the extent of glioma surgical removal continue to 
influence the field of neurosurgical oncology with posi-
tive effects of gross total tumor resection documented 
in selected patients as the most important factor af-
fecting the prognosis10-15.  Accordingly, the majority of 
patients (45.5%) from this series underwent gross tu-
mor resection as a surgical method of choice (Table 2). 
However, such a treatment strategy may not be always 
beneficial, especially in elderly patients, since it may 
bring a higher risk of complications, which may rule out 
satisfactory outcome16. Therefore, a stereotactic biopsy 
to provide tissue specimen for histopathological diag-
nosis should be performed in patients who would not 
tolerate a large cranial surgery due to their age, and/or 
unresectable tumors17. It appears that a stereotactic bi-
opsy is well justified in strictly selected patients when 
the survival and the quality of life are concerned18. It 
was performed in substantial portion of patients (41%) 
from our series (Table 2), and the majority of these pa-
tients belonged to the elderly.
The development of peri-operative motor or language 
deficit was associated with decreased progression free 
survival19. The most frequent peri-operative complica-
tion in our series was a transient speech difficulty (Table 
3), which did not affect in-hospital mortality at all. 
Venous thromboembolism, including deep venous 
thrombosis (DVT), and pulmonary embolism, often 
complicate the post-operative course of brain glioma 
patients20, primarily due to their prolonged immobility. 
Regardless of the lack of routine prophylactic anticoag-
ulation therapy in the post-operative setting of patients 
in our series, the incidence of DVT was low (Table 3), 
and comparable to that observed in other institutional 
series21.
Approximately one third of glioma patients experience 
a seizure during the post-treatment period, regardless 
of previous history of epi attacks22, 23. Seizures were ob-
served as the most frequent post-operative complica-
tion in our series too (Table 3). 
Patients with surgical complications experience longer 
hospitalization and a significantly increased risk of in-
hospital mortality6. Therefore, to rise the efficacy and 
safety of brain glioma surgery, an assortment of state-
of-the-art techniques has been developed including 
intra-operative ultrasound, computed tomography (CT) 
and magnetic resonance imaging (MRI), neuronaviga-
tion, brain mapping, cortical stimulation, fluorescence-
guided tumor resection, etc.24. Thorough knowledge 
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Metode: Analizirana je skupina bolesnika operiranih 
zbog glioma mozga tijekom dvogodišnjeg razdoblja. 
Promatrana je učestalost i vrsta komplikacija, kao i vri-
jeme njihova nastanka. Također su zabilježeni podaci 
o dobi i spolu bolesnika te stupnju tumorske resekcije. 
Komplikacije su dihotomizirane kao perioperacijske i 
poslijeoperacijske varijable čija je moguća povezanost 
uspoređivana s istraživanim pokazateljima.
Rezultati: Tranzitorni neurološki deficit bio je najuče-
stalija perioperacijska komplikacija. Epileptički napa-
daj, meningitis i trajni neurološki ispad zabilježeni su 
kao najčešća poslijeoperacijska komplikacija.
Zaključak: Spol i dob bolesnika, kao i stupanj tumorske 
resekcije nisu utjecali na nastanak komplikacija kirur-
škog liječenja glioma mozga, koje je moguće izbjeći 
pažljivim odabirom bolesnika, multidisciplinarnim pre-
doperacijskim planiranjem i primjenom obzirne neuro-
kirurške tehnike poduprte uporabom najsuvremenije 
operacijske opreme.
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Sažetak
Uvod: Gliomi mozga najučestaliji su smrtonosni primar-
ni intrakranijski tumori. Unatoč tomu, njihovo radikal-
no kirurško uklanjanje i nadalje ostaje najuspješnija 
metoda liječenja kojom se može usporiti napredova-
nje bolesti i donekle produljiti život ovakvih bolesnika. 
Međutim, agresivno kirurško liječenje može povećati 
opasnost nastanka neuroloških, regionalnih i sustavnih 
komplikacija, koje se može pokušati izbjeći boljom pri-
premom prije i tijekom operacije, kao i uporabom su-
vremenih neurokirurških tehnika.
Cilj: Analizirati učestalost i vrstu perioperacijskih i posli-
jeoperacijskih komplikacija u kirurški liječenih bolesnika s 
gliomom mozga. Na temelju obrade rezultata, uspostaviti 
preporuke za sprječavanje nastanka komplikacija.
STRATEGIJE U PREVENCIJI KOMPLIKACIJA KIRURŠKOG LIJEČENJA 
GLIOMSKIH TUMORA MOZGA: ANALIZA SKUPINE SLUČAJEVA
